×
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
CVE:NSCI

Nanalysis Scientific Stock Forecast, Price & News

C$0.95
+0.02 (+2.15%)
(As of 06/29/2022 02:18 PM ET)
Add
Compare
Today's Range
C$0.95
C$0.95
50-Day Range
C$0.86
C$1.32
52-Week Range
C$0.86
C$1.76
Volume
44,800 shs
Average Volume
95,361 shs
Market Capitalization
C$89.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive NSCI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nanalysis Scientific and its competitors with MarketBeat's FREE daily newsletter.

NSCI Stock Forecast (MarketRank)

Overall MarketRank

0.83 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
Nanalysis Scientific logo

About Nanalysis Scientific (CVE:NSCI)

Nanalysis Scientific Corp., develops, manufactures, and sells compact nuclear magnetic resonance (NMR) spectrometers and magnetic resonance imaging equipment for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. It operates through three segments: Nanalysis, RS2D, and Corporate. The company also offers software module packages; manufactures and sells cutting-edge electronics components for precision analytical instruments; and provides monitoring and supporting services for its NMR technologies. It sells its products directly, as well as through a network of distributors worldwide. The company is headquartered in Calgary, Canada.

NSCI Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Scientific & Technical Instruments
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$18.32 million
Cash Flow
C$0.19 per share
Book Value
C$0.43 per share

Miscellaneous

Free Float
N/A
Market Cap
C$89.36 million
Optionable
Not Optionable
Beta
N/A














Nanalysis Scientific Frequently Asked Questions

How has Nanalysis Scientific's stock price performed in 2022?

Nanalysis Scientific's stock was trading at C$1.45 at the beginning of 2022. Since then, NSCI stock has decreased by 34.5% and is now trading at C$0.95.
View the best growth stocks for 2022 here
.

Who are Nanalysis Scientific's key executives?

Nanalysis Scientific's management team includes the following people:
  • Mr. Martin Andrew Burian CPA, CA, CPA, Corp. Sec. & Chairman (Age 58, Pay $7.5k)
  • Mr. Sean Krakiwsky M.Sc., Founder, CEO, Pres & Director (Age 52, Pay $288k)
  • Mr. Luke Caplette C.A., CPA, Chief Financial Officer (Age 33, Pay $187.22k)
  • Mr. Julien Muller, Chief Technology Officer
  • Dr. Heather Phillips, Director of Operations
  • Mr. Matthew Selinger, Investor Relations Mang.
  • Dr. Matt Zamora, Sales Mang.
  • Dr. Susanne Riegel, Director of Marketing & Product Mang.
  • Dr. Greg McFeetors, Head of Manufacturing
  • Mr. Neal Gallagher, Head of Product Devel.

What other stocks do shareholders of Nanalysis Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nanalysis Scientific investors own include Brookfield Infrastructure Partners (BIP.UN), Big 5 Sporting Goods (BGFV), BlackBerry (BB), Brookfield Asset Management (BAM.A), AstraZeneca (AZN), Ayro (AYRO), (ATE), Digital Turbine (APPS), Alamos Gold (AGI) and Air Canada (AC).

What is Nanalysis Scientific's stock symbol?

Nanalysis Scientific trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NSCI."

How do I buy shares of Nanalysis Scientific?

Shares of NSCI and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Nanalysis Scientific's stock price today?

One share of NSCI stock can currently be purchased for approximately C$0.95.

How much money does Nanalysis Scientific make?

Nanalysis Scientific (CVE:NSCI) has a market capitalization of C$89.36 million and generates C$18.32 million in revenue each year.

How can I contact Nanalysis Scientific?

The official website for Nanalysis Scientific is www.nanalysis.com. The company can be reached via phone at 403-769-9499.

This page (CVE:NSCI) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.